SCHEMBL9034644

SCHEMBL9034644

O=Cc1ccnc2c(Cl)ccc(Cl)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.52
CCR8 P51685 2/20 0.52
CCR5 P51681 1/20 0.52
TDP1 Q9NUW8 4/20 0.35
KMT2A Q03164 6/20 0.35
KDM4E B2RXH2 5/20 0.35
MEN1 O00255 5/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
HSP90AA1 P07900 3/20 0.35
NPC1 O15118 1/20 0.35
IDO1 P14902 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NR4A2 P43354 1/20 0.34
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
ALDH1A1 P00352 6/20 0.32
MAPT P10636 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3912822 0.74 CCR1 (0.63) CCR1CCR8CCR5TDP1KMT2A
SCHEMBL9034116 0.74 CCR1 (0.69) CCR1CCR8CCR5TDP1KMT2A
SCHEMBL29216607 0.72 CCR1 (0.55) CCR1CCR8CCR5TDP1KMT2A
SCHEMBL29953393 0.69 CCR1 (0.47) CCR1CCR8CCR5TDP1KMT2A
SCHEMBL9032891 0.69 CCR1 (0.46) CCR1CCR8CCR5TDP1KMT2A
SCHEMBL13257417 0.69 CCR1 (0.47) CCR1CCR8CCR5TDP1KMT2A
SCHEMBL20125333 0.69 KDM5A (0.55) CCR1CCR8CCR5TDP1KMT2A
SCHEMBL8069040 0.69 TDP1 (0.48) CCR1CCR8CCR5TDP1KMT2A
SCHEMBL29958532 0.69 KMT2A (0.47) CCR1CCR8CCR5KMT2AKDM5A
SCHEMBL748190 0.69 CCR1 (0.50) CCR1CCR8CCR5TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5589484-A TREATMENT OF HELICOBACTER INFECTIONS, ANTIULCER JANSSEN PHARMACEUTICA N.V. (BE) 1996-12-31 US disclosed
EP-0666855-B1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY JANSSEN PHARMACEUTICA NV (BE) 1996-09-18 EP disclosed
EP-0666855-A1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY. JANSSEN PHARMACEUTICA NV (BE) 1995-08-16 EP disclosed
WO-1994010164-A1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1994-05-11 WO disclosed